World Drug Safety Congress Americas 2024
October 29-30, 2024 | Boston, Massachusetts, USA
Your RWD Solution for Informed Drug Safety Decisions.
See us at Booth 626
Resources
Where Real-World Data Meets Pharmacovigilance Excellence
At TriNetX, we are revolutionizing drug safety through our commitment to providing unparalleled access to real-world data insights. Our cutting-edge platforms, extensive data analytics, and a team of seasoned experts empower drug safety professionals to unlock the transformative potential of real-world data and real-world evidence in pharmacovigilance.
What truly sets us apart is our fully integrated, comprehensive, global, real-world data (RWD) and evidence that empowers users to make data-driven decisions. EVIDEX® makes the most complex and demanding signal detection and management requirements easier by refining signals through analytics supported by the power of TriNetX global RWD.
Discover What’s Next in PV at Booth 626
WDSC US 2024, TriNetX, Booth #626
Exhibit Hall Hours:
- Tuesday, 29 October, 8:00 AM – 6:30 PM
- Wednesday, 30 October, 8:00 AM – 3:35 PM
Visit us at Booth 626 to discover how TriNetX empowers drug safety professionals with actionable evidence, enhancing decision-making, and improving patient outcomes. Our team will be on hand to demonstrate the capabilities of EVIDEX®, answer your questions, and explore how we can support your pharmacovigilance and drug safety initiatives. Don’t miss the chance to learn more about our solutions and how we’re driving safer healthcare.
Connect with TriNetX Drug Safety Experts
Join us at the World Drug Safety Congress to explore how TriNetX can become your premier partner in the next generation of pharmacovigilance. Browse speaking engagements from the curated conference agenda below.
Signal Refinement Using Real-World Data
Track: Artificial Intelligence and Machine Learning
Date/Time: October 29, 2024 at 12:30 pm
Location: Room 050
Speaker: Jeffrey Brown, PhD, Chief Scientific Officer, TriNetX
Real-world data (RWD) is essential in pharmacovigilance (PV), providing rich insights into drug safety and patient outcomes beyond clinical trials. This talk will explore how RWD can be effectively harnessed in PV processes, improving signal detection and safety monitoring. As we enter an era of AI-driven innovation, it’s crucial to recognize that AI’s success depends heavily on the quality, quantity, and diversity of the data it processes.
Incorporating real-world data into pharmacovigilance is redefining how we monitor and evaluate drug and vaccine safety. As AI and machine learning become integrated into the safety surveillance process, the quality, reliability, and contextualization of the data will be the driving force behind generating meaningful insights.
Evaluating Success of GLP-1 Agonists and Metformin for Weight Reduction in Polycystic Ovary Syndrome Patients in Real-World Data: A Retrospective, Comparative Analysis of Electronic Health Record Data
Track: Networking, posters, expo hall
Dates/Times:
October 29, 2024 at 10:30 AM & 1:10 PM
October 30, 2024 at 11:15 AM & 1:45 PM
Location: Hall C
Presenter: Tessa Sagarino, Analyst, Clinical Study Feasibility & Analytics, TriNetX
Poster description and findings: Patients with Polycystic Ovary Syndrome (PCOS) often experience weight gain as a result of insulin resistance or elevated androgen levels. In this study, the TriNetX federated network of de-identified real world data was leveraged to identify overweight PCOS patients receiving treatment exclusively with Glucagon-like peptide-1 (GLP-1) agonists or Metformin and compare for the outcome of transformation to a normal-range Body Mass Index (BMI) value. Patients with PCOS receiving GLP-1 agonists were found to be 1.7 times more likely to see this transformation to normal-range BMI in one year following treatment and 1.9 times more likely to see this transformation in the two years following treatment, when compared to patients receiving Metformin.
Pre-Book Meetings with TriNetX
Join us at WDSC Americas 2024 to explore how TriNetX can enhance your pharmacovigilance capabilities. Meet our subject-matter experts to discuss how our real-world data solutions can support your specific drug safety needs and contribute to advancing safety for all.
Drug Safety Resources
Explore our curated collection of high-quality materials designed to support pharmacovigilance professionals, researchers, and industry stakeholders.
Webinar: Go Beyond the Limits of Legacy PV with RWD
The revolution in drug safety data is underway. The advent of RWD, together with technologies to aggregate, standardize, and analyze it, have turned Pharmacovigilance (PV) specialists into evidence generation leaders.
Download: GVP Module IX for Signal Management Guide
This guide will summarize the process outlined by GVP IX and discuss how EVIDEX® Signal Management can help organizations efficiently comply.
Product Preview: EVIDEX®
See how the EVIDEX® platform makes the most complex and demanding signal detection and management requirements easier by refining signals through analytics supported by the power of TriNetX global RWD.
Explore TriNetX PV Publications & Resources
TriNetX aims to advance pharmacovigilance by delivering cutting-edge research, in-depth publications, and essential resources. Discover valuable insights and tools to enhance your understanding and practice of drug safety and signal management.
Let’s Talk
Reserve your time with TriNetX experts live at WDSC EU 2024. Space is limited.
Our Mission
Our mission is to build a global data and analytics ecosystem that provides real-world insights to address the most pressing health challenges. This mission resonates beyond the walls of our organization, echoing in the corridors of our esteemed health care and industry partners. Every decision, innovation, and feature is fueled by our unwavering dedication to positively connect the world to improve human health.
Going Beyond What's Possible
As a global force, TriNetX continues to navigate uncharted territories with an unwavering commitment to revolutionizing the healthcare ecosystem.
Far beyond being a repository of information, TriNetX serves as a strategic partner in connecting health systems, providers, and researchers worldwide through our extensive real-world patient data that runs a mile wide and a mile deep.
From trial operations to evidence generation, we put you at the forefront of discovery.
Clinical Trial Design & Optimization
Data Sets & Analytics
Non-US Oncology
Real-World Evidence Generation
Pharmacovigilance & Drug Safety
Book a Meeting at WDSC US
Please complete the below to request a meeting at the World Drug Safety Congress Americas 2024 in Boston, Massachusetts this October 29-30, 2024.